Tokyo, Aug. 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058691) titled 'Efficacy of imeglimin in stepping down from multiple daily insulin injection with DPP-4 inhibitor' on Aug. 30.
Study Type:
Observational
Primary Sponsor:
Institute - Toho university school of medicine
Condition:
Condition - type 2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the insulin dosage reduction effect of adding imeglimin to patients treated with multiple daily insulin injection and DPP-4 inhibitor.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Hospitalize...